# FDA Inspection 1087214 - The American National Red Cross - April 03, 2019

Source: https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross/e119b65b-a5e3-4979-bc0a-5874437707cd
Source feed: FDA_Inspections

> FDA Inspection 1087214 for The American National Red Cross on April 03, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087214
- Company Name: The American National Red Cross
- Inspection Date: 2019-04-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1307622 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross/e1f0b475-7a87-4082-a000-e8eb21590f28)
- [FDA Inspection 1307622 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross/77c30829-16de-4cfb-a797-9e33e865112a)
- [FDA Inspection 1195578 - 2023-01-20](https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross/d049cf62-715b-4a23-88bb-3891191030ee)
- [FDA Inspection 1195578 - 2023-01-20](https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross/7db949e0-ead5-470c-b99c-83060f96e66f)
- [FDA Inspection 1015006 - 2017-06-15](https://www.keypedia.com/records/fda_inspections/the-american-national-red-cross/3d57e23a-61f9-4762-b684-316b48e7c587)

Company: https://www.keypedia.com/companies/the-american-national-red-cross/b0f130b3-df2a-4031-975d-93e5b890b426

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d